Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial

Mar 30, 2026

News

Early Screening for Cardiac Amyloid Using a History of Bilateral Carpal Tunnel Syndrome

May 12, 2026

New Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutrisiran as a First-Line Treatment Option Across ATTR-CM Patient Populations, Including Patients with a High Disease Burden

May 12, 2026

First look at Wainua in ATTR-CM Phase III CARDIO-TTRansform data

May 11, 2026

Eye dryness, floaters common in hATTR-PN, but more research needed

May 11, 2026

New study explores how to improve diagnosis of a frequently missed heart condition

May 11, 2026

More in News

Education

Symptoms of Cardiac Amyloidosis

May 12, 2026

What to Know About Stiff Heart Syndrome (Cardiac Amyloidosis)

May 12, 2026

Evolving Management of Transthyretin Amyloid Cardiomyopathy: From Early Recognition to Personalized Care

May 09, 2026

ATTR-CM - Finding Answers for a Hidden Heart Condition

May 08, 2026

ATTR and Swelling (Edema): What Causes It?

May 08, 2026

More in Education

Community Center

Hi I've Recently been Diagnosed with Cardiac Amyloidosis.

May 13, 2026

Hi I've Recently been Diagnosed with Cardiac Amyloidosis.

May 13, 2026

Radcliffe Cardiology

May 11, 2026

Rare disease advisor

May 09, 2026

Bayer plans filings for cardiac amyloidosis imaging agent

May 07, 2026

More in Community Center

Video